Pfizer Reaches Whopping $150 Billion Deal With Allergan


pfizerPharmaceutical giant Pfizer sealed the deal in a blockbuster $150 billion merger with Irish-based drug maker Allergan.

In one of the largest transactions in industry history, Allergan will acquire Pfizer in a maneuver known as a reverse merger, which will allow the U.S. company to legally move abroad and lower its tax bill.

The tie-up comes despite the Obama administration’s effort to thwart such mergers and the loss of corporate tax revenue. Read more at The New York Times.



Please enter your comment!
Please enter your name here